Kowal Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-23
Closed -$2K – 172
2021
Q3
$2K Buy
+23
New +$1.93K ﹤0.01% 776

Other funds holding ARKG

Kowal Investment Group's ARKG Position: Q4 2021 in Review

Kowal Investment Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 23 shares — an estimated $2K sold.

Kowal Investment Group first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Kowal Investment Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Kowal Investment Group sold 23 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $2K.
  • Kowal Investment Group first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
  • Kowal Investment Group's ARK Genomic Revolution ETF position peaked at $2K in Q3 2021.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.